4.6 Article

Parental Attitudes Towards Vaccination Against COVID-19 in China During Pandemic

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu et al.

Summary: The study showed that CoronaVac vaccine is safe and well tolerated in older adults, and is able to induce neutralizing antibody levels. The highest dose of 3 μg of the vaccine can generate neutralizing antibody levels similar to the 6 μg dose, supporting the use of the 3 μg dose CoronaVac in phase 3 trials.

LANCET INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

Editorial Material Medicine, General & Internal

Acute covid-19 and multisystem inflammatory syndrome in children

Jessica H. Rubens et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Immunology

Access to Vaccination Information and Confidence/Hesitancy towards Childhood Vaccination: A Cross-Sectional Survey in China

Fanxing Du et al.

Summary: This study in China investigated the associations between vaccination information sources and vaccine confidence or hesitancy. The majority of caregivers had multiple sources, with professional, media, and peers being the most common. Caregivers who received information from professional sources were more confident in vaccine safety, while those who relied on media sources were more hesitant.

VACCINES (2021)

Article Medicine, General & Internal

Parents' willingness and attitudes concerning the COVID-19 vaccine: A cross-sectional study

Meltem Yilmaz et al.

Summary: The study found that parents' willingness for their children to receive the COVID-19 vaccine was low, with the only characteristic affecting this willingness being whether the parents were healthcare workers. Parents' willingness and positive attitudes towards the COVID-19 vaccine are factors that increase acceptance of the COVID-19 vaccine for their children.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

News Item Medicine, General & Internal

Covid-19: FDA authorises Pfizer vaccine for children 12-15

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanriover et al.

Summary: The study presented the interim efficacy and safety results of the CoronaVac vaccine in a phase 3 clinical trial in Turkey, demonstrating high efficacy against PCR-confirmed symptomatic COVID-19 with good safety and tolerability profile. Results showed significant differences in the frequency of any adverse events between the vaccine and placebo groups, indicating excellent protective effects of the vaccine.

LANCET (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han et al.

Summary: The study evaluated the safety, tolerability, and immunogenicity of the candidate COVID-19 vaccine CoronaVac containing inactivated SARS-CoV-2 in children and adolescents aged 3-17 years. The research findings indicate that the 3.0 μg dose induced higher levels of neutralizing antibodies compared to the 1.5 μg dose, supporting the use of the 3.0 μg dose for further studies in this age group.

LANCET INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

Otavio Ranzani et al.

Summary: The study evaluates the effectiveness of the CoronaVac vaccine in the elderly population aged >= 70 years in Sao Paulo state, Brazil during widespread circulation of the gamma variant. The vaccine was found to significantly reduce the risk of symptomatic covid-19, hospital admissions, and deaths after completion of the two-dose regimen, but the effectiveness decreases with age among the elderly population.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children

Soo-Han Choi et al.

Summary: The study found that 76.5% of parents in South Korea intend to get vaccinated against COVID-19, 64.2% intend to have their children vaccinated, but only 49.6% of children responded that they would get vaccinated. Factors such as parents' confidence in the safety of vaccines, willingness to vaccinate themselves, and awareness of the need to vaccinate children were associated with parents' intention to vaccinate their children.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Pediatrics

CoVID-19: Parent and caregiver concerns about reopening New Zealand schools

Emma Jeffs et al.

Summary: Despite reassurances from multiple trusted sources that transmission of COVID-19 in schools is unlikely and the low number of cases in New Zealand, parents and caregivers still express high levels of concern about their children catching the virus at school.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2021)

Editorial Material Medicine, General & Internal

Planning for a COVID-19 Vaccination Program

Sarah Schaffer DeRoo et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Infectious Diseases

Herd immunity and vaccination of children for COVID-19

Thirumalaisamy P. Velavan et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Review Medicine, General & Internal

Face-to-face interventions for informing or educating parents about early childhood vaccination (Review)

Jessica Kaufman et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Review Medicine, General & Internal

Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence

Heather M. R. Ames et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Biochemistry & Molecular Biology

Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing

Jason M. Glanz et al.

PLOS BIOLOGY (2015)

Review Biotechnology & Applied Microbiology

What are the factors that contribute to parental vaccine-hesitancy and what can we do about it?

Sarah E. Williams

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

Article Biotechnology & Applied Microbiology

A pilot study on the effects of individually tailored education for MMR vaccine-hesitant parents on MMR vaccination intention

Charitha Gowda et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)

Article Public, Environmental & Occupational Health

Prevalence of Parental Concerns About Childhood Vaccines The Experience of Primary Care Physicians

Allison Kempe et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2011)